Dehydrozingerone exerts beneficial metabolic effects in high-fat diet-induced obese mice via AMPK activation in skeletal muscle

J Cell Mol Med. 2015 Mar;19(3):620-9. doi: 10.1111/jcmm.12455. Epub 2015 Jan 12.

Abstract

Dehydrozingerone (DHZ) exerts beneficial effects on human health; however, its mechanism of action remains unclear. Here, we found that DHZ suppressed high-fat diet-induced weight gain, lipid accumulation and hyperglycaemia in C57BL/6 mice and increased AMP-activated protein kinase (AMPK) phosphorylation and stimulated glucose uptake in C2C12 skeletal muscle cells. DHZ activated p38 mitogen-activated protein kinase (MAPK) signalling in an AMPK-dependent manner. Inhibiting AMPK or p38 MAPK blocked DHZ-induced glucose uptake. DHZ increased GLUT4 (major transporter for glucose uptake) expression in skeletal muscle. Glucose clearance and insulin-induced glucose uptake increased in DHZ-fed animals, suggesting that DHZ increases systemic insulin sensitivity in vivo. Thus, the beneficial health effects of DHZ could possibly be explained by its ability to activate the AMPK pathway in skeletal muscle.

Keywords: AMPK; curcumin analogue; dehydrozingerone; glucose uptake; metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / antagonists & inhibitors
  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism*
  • Animals
  • Biological Transport / drug effects
  • Biological Transport / genetics
  • Blood Glucose / metabolism
  • Cells, Cultured
  • Curcumin / analogs & derivatives
  • Deoxyglucose / metabolism
  • Diet, High-Fat
  • Enzyme Activation
  • Glucose / metabolism*
  • Glucose Transporter Type 4 / biosynthesis
  • Hyperglycemia / drug therapy
  • MAP Kinase Signaling System / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Muscle Fibers, Skeletal / metabolism*
  • Obesity
  • Phosphorylation / drug effects
  • RNA Interference
  • RNA, Small Interfering
  • Rats
  • Styrenes / pharmacology*
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Blood Glucose
  • Glucose Transporter Type 4
  • RNA, Small Interfering
  • Slc2a4 protein, mouse
  • Styrenes
  • methyl-3-methoxy-4-hydroxystyryl ketone
  • Deoxyglucose
  • p38 Mitogen-Activated Protein Kinases
  • AMP-Activated Protein Kinases
  • Curcumin
  • Glucose